Immucor Inc. expected to Report Q3 2010 Results on April 5, 2010. This event was calculated by Capital IQ (Created on January 20, 2010).

Immucor Inc. reported unaudited consolidated earnings results for the second quarter and six months ended November 30, 2009. For the quarter, the company reported net income was $19.7 million or $0.28 per diluted share on net sales of $82.6 million against net income of $17.3 million or $0.24 per diluted share on net sales of $73.0 million for the same period last year. Income from operations was $30.7 million against $27.9 million for the same period last year. Income before income taxes was $30.7 million against $27.1 million for the same period last year. Revenue in the quarter benefited from both price and volume contributions. Revenue in the quarter, as compared with the second quarter of fiscal 2009, was favorably impacted by approximately $1.9 million due to fluctuations in foreign currency exchange rates. For the six months, the company reported net income was $41.0 million or $0.58 per diluted share on net sales of $165.6 million against net income of $37.3 million or $0.52 per diluted share on net sales of $146.2 million for the same period last year. Income from operations was $64.0 million against $58.5 million for the same period last year. Income before income taxes was $64.3 million against $58.0 million for the same period last year. Cash flow from operations was $34.1 million, compared with $32.3 million in the prior year. Purchases of property and equipment were $4.5 million, compared with $3.6 million in the prior year. The company provided earnings guidance for the fiscal 2010. The company continues to expect fiscal 2010 consolidated revenue in the range of $322 million to $332 million. The company continues to expect diluted earnings per share to be in the range of $1.10 to $1.17 for fiscal 2010. The company expects expenses related to the Project in fiscal 2010 to be in the range of $6.0 million to $7.0 million, as compared with previous expectations of $4.0 million to $4.5 million.

Immucor Inc. Presents at J.P. Morgan 28th Annual Healthcare Conference 2010, Jan-14-2010 through Jan-14-2010. Venue: Westin St. Francis Drake Hotel, 335 Powell Street, San Francisco, California, United States.